Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Bay City Capital
3942
Bay City Capital
Suggest edits
Follow us
Also headquartered in San Francisco
Ahelpfulghost
Twitter
Uber
Instagram
TikTok
Airbnb
Lyft
Coinbase
Fitbit
LinkedIn
Overview
News
Investments
28
Portfolio
Portfolio Tracker
Add info
Pulse 2.0
Iterum Therapeutics (ITRM) Stock: Why It Surged Over 20% Today
Pulse 2.0
Kezar Life Sciences (KZR) Stock: Why It Surged 43.43%
Pulse 2.0
Kezar Life Sciences (KZR) Stock: Why The Price Surged Today
Northstack
Oculis raises $57m Series C led by BVCF Management and Hyfinity Investments
$100,500,000
Venture capital (Series B)
FinSMEs
,
Pulse 2.0
Xilio Therapeutics Raises $100.5M in Series B Financing
Acquisition
Xconomy
,
FinSMEs
Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira
the home of AI info
Menlo Therapeutics Inc. (MNLO)'s Financial Results Comparing With Minerva Neurosciences Inc ...
Electric Shaver For Women Reviews
Tria Beauty Hair Removal Laser 4X Review
Silicon Canals
Swiss startup Oculis secures €13.8M funding to treat ophthalmic diseases
$15,711,870
Venture capital (Series B)
FinSMEs
,
PE HUB
Oculis Raises CHF15.5M in Extension of Series B Financing
$30,000,000
Venture capital (Series A)
FinSMEs
,
PE HUB
,
MedCity News
, +1
Akrevia Therapeutics Raises $30M in Series A Financing
Funding
Health
$75,000,000
IPO
PE HUB
VC-backed Kezar Life Sciences unveils IPO
Stock markets
Health
Bloomberg
Dermira Reminds Investors What Binary Means in Biotech
Stock markets
Health
Xconomy
Dermira Abandons Acne Drug After Phase 3 Flops, Stock Price Craters
Health
FinSMEs
Menlo Therapeutics Announces IPO Pricing
Stock markets
Health
PE HUB
| Oculis nabs $20.3 mln Series B
Funding
Health
$20,300,000
Venture capital (Series B)
Norðurskautið
,
FinSMEs
Oculis raises $20.3m Series B round to advance treatment for Ophthalmic Diseases
Funding
Health
Xconomy
Dermira Commits $135M for Global Rights to Roche Eczema Drug
Health
$50,000,000
Venture capital (Series C)
FinSMEs
,
prnewswire
Menlo Therapeutics Raises $50M in Series C Financing
$65,000,000
Venture capital (Series B)
PE HUB
Iterum grabs $65 mln Series B
Messaging
